Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Prepaid Assets (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Prepaid Assets for 2 consecutive years, with $26954.0 as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 45.94% to $26954.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $26954.0, a 45.94% increase, with the full-year FY2025 number at $740193.0, changed N/A from a year prior.
  • Prepaid Assets was $26954.0 for Q4 2025 at Neuphoria Therapeutics, down from $222319.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $740193.0 in Q2 2025 to a low of $18469.0 in Q4 2024.